PB1763: A PHASE 1/2 STUDY TO EVALUATE PONATINIB WITH CHEMOTHERAPY IN PEDIATRIC PATIENTS WITH RELAPSED/RESISTANT/INTOLERANT PHILADELPHIA CHROMOSOME–POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA OR WITH T315I MUTATION

Những quyển sách tương tự

• Efficacy of Inotuzumab Ozogamicin plus Ponatinib Followed by Allogeneic Stem Cell Transplantation in a Patient with Relapsed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
  Bằng: Ilina Micheva, et al.
  Được phát hành: (2021-01-01)
• Therapeutic potential of ruxolitinib and ponatinib in patients with <i>EPOR</i>-rearranged Philadelphia chromosome-like acute lymphoblastic leukemia
  Bằng: Lisa M. Niswander, et al.
  Được phát hành: (2021-07-01)
• Daratumumab for relapsed/refractory Philadelphia-positive acute lymphoblastic leukemia
  Bằng: Chezi Ganzel, et al.
  Được phát hành: (2018-10-01)
• Successful treatment of two cases with Philadelphia-chromosome positive acute lymphoblastic leukemia who relapsed after allogeneic stem cell transplantation and the treatments with novel immunotherapies and ponatinib
  Bằng: Takayoshi Tachibana, et al.
  Được phát hành: (2024-12-01)
• PB1762: PONATINIB VERSUS IMATINIB WITH REDUCED-INTENSITY CHEMOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED PHILADELPHIA CHROMOSOME–POSITIVE (PH+) ACUTE LYMPHOBLASTIC LEUKEMIA (ALL): PHALLCON STUDY
  Bằng: E. Jabbour, et al.
  Được phát hành: (2022-06-01)